Search Results - "von der Mark, Elisabeth"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2

    Synthesis and Structure−Activity Studies of Novel Orally Active Non-Terpenoic 2,3-Oxidosqualene Cyclase Inhibitors by Dehmlow, Henrietta, Aebi, Johannes D, Jolidon, Synèse, Ji, Yu-Hua, von der Mark, Elisabeth M, Himber, Jacques, Morand, Olivier H

    Published in Journal of medicinal chemistry (17-07-2003)
    “…New orally active non-terpenoic inhibitors of human 2,3-oxidosqualene cyclase (hOSC) are reported. The starting point for the optimization process was a set of…”
    Get full text
    Journal Article
  3. 3

    Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays by Dernick, Gregor, Obermüller, Stefan, Mangold, Cyrill, Magg, Christine, Matile, Hugues, Gutmann, Oliver, von der Mark, Elisabeth, Handschin, Corinne, Maugeais, Cyrille, Niesor, Eric J.

    Published in Journal of lipid research (01-12-2011)
    “…The composition of lipoproteins and the association of proteins with various particles are of much interest in the context of cardiovascular disease. Here, we…”
    Get full text
    Journal Article
  4. 4

    Lipid and apoprotein composition of HDL in partial or complete CETP deficiency by Niesor, Eric J, von der Mark, Elisabeth, Calabresi, Laura, Averna, Maurizio, Cefalù, Angelo B, Tarugi, Patrizia, Nilsson, Peter, Dernick, Gregor

    Published in Current vascular pharmacology (01-07-2012)
    “…Hyperalphalipoproteinemia, as observed in patients who are either homozygous or heterozygous for cholesteryl ester transfer protein (CETP) deficiency, has been…”
    Get more information
    Journal Article
  5. 5

    Human Monocyte-Derived Macrophages Express an [nearly =] 120-kD Ox-LDL Binding Protein With Strong Identity to CD68 by van der Kooij, Maaike A, von der Mark, Elisabeth M, Kruijt, J. Kar, van Velzen, Agnes, van Berkel, Theo J.C, Morand, Olivier H

    “…A protein that specifically binds oxidized LDL (Ox-LDL) has recently been characterized in mouse peritoneal macrophages and identified as macrosialin, a…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Oxidosqualene Cyclase (OSC) Inhibitors for the Treatment of Dyslipidemia by Henrietta Dehmlow, Ralf Thoma, Armin Ruf, Narendra Panday, Elisabeth Von Der Mark, Olivier Morand, Hans Peter Märki, Manfred Kansy, Peter Hartman, Philippe Coassolo, Alexander Chucholowski, Denise Blum-Kaelin, Johannes Aebi, Jean Ackermann, Tanja Schulz-Gasch

    Published in Chimia (01-03-2005)
    “…Novel inhibitors of oxidosqualene cyclase (OSC) for the treatment of dyslipidemia are reported. Starting point for the chemistry program was a set of compounds…”
    Get full text
    Journal Article
  8. 8

    Evidence for a role of CETP in HDL remodeling and cholesterol efflux: Role of cysteine 13 of CETP by Maugeais, Cyrille, Perez, Anne, von der Mark, Elisabeth, Magg, Christine, Pflieger, Philippe, Niesor, Eric J.

    Published in Biochimica et biophysica acta (01-11-2013)
    “…Cholesteryl ester transfer protein (CETP), a key regulator of high-density lipoprotein (HDL) metabolism, induces HDL remodeling by transferring lipids between…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Abstract 69: The Increase in Dalcetrapib-Induced HDL Remodeling Is Dependent on Cysteine 13 of Cholesteryl Ester Transfer Protein and Does Not Involve Phospholipid Transfer Protein by Maugeais, Cyrille, Perez, Anne, von der Mark, Elisabeth, Tetaz, Tim, Schmid, Georg, Niesor, Eric J

    “…Abstract only Introduction: Inhibition of the cholesteryl ester transfer between HDL and apoB-containing lipoproteins by dalcetrapib requires cysteine 13 (C13)…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13